Insider Transactions in Q2 2021 at Esperion Therapeutics, Inc. (ESPR)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 28
2021
|
Joanne M. Foody Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
62,528
+50.0%
|
-
|
|
May 27
2021
|
Tracy M Woody Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,376
+30.34%
|
-
|
|
May 27
2021
|
Daniel Janney Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,376
+34.55%
|
-
|
|
May 27
2021
|
Nicole Vitullo Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,376
+28.04%
|
-
|
|
May 27
2021
|
Antonio M Jr Md D Phil Gotto Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,376
+34.55%
|
-
|
|
May 27
2021
|
Jay Shepard Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,376
+34.55%
|
-
|
|
May 27
2021
|
Mark E Mcgovern Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,376
+30.31%
|
-
|
|
May 27
2021
|
Alan Fuhrman Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,376
+32.89%
|
-
|
|
May 27
2021
|
Jeffrey Berkowitz Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,376
+34.55%
|
-
|
|
May 24
2021
|
Target N V Biotech > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
100,000
+2.18%
|
$2,000,000
$20.22 P/Share
|
|
May 19
2021
|
Target N V Biotech > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
200,000
+4.37%
|
$4,000,000
$20.37 P/Share
|
|
May 17
2021
|
Sheldon L. Koenig President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+28.57%
|
-
|
|
May 06
2021
|
Target N V Biotech > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
80,000
+1.88%
|
$1,600,000
$20.57 P/Share
|
|
May 05
2021
|
Target N V Biotech > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
150,000
+3.53%
|
$3,000,000
$20.02 P/Share
|